Cargando…
Have We Found the Key to Unravel Treatment Development Lags for Rare Cancers?: MASTER KEY Project
Autores principales: | Okuma, Hitomi S., Fujiwara, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766785/ https://www.ncbi.nlm.nih.gov/pubmed/31121054 http://dx.doi.org/10.1002/cpt.1453 |
Ejemplares similares
-
MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial
por: Okuma, Hitomi S., et al.
Publicado: (2020) -
A Transcriptional Signature for Active TB: Have We Found the Needle in the Haystack?
por: Cattamanchi, Adithya, et al.
Publicado: (2013) -
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
por: Xu-Monette, Zijun Y., et al.
Publicado: (2017) -
Why Have Detection, Understanding and Management of Kidney Hypoxic Injury Lagged behind Those for the Heart?
por: Abassi, Zaid, et al.
Publicado: (2019) -
Understanding cardiovascular disease: a journey through the genome (and what we found there)
por: Lara-Pezzi, Enrique, et al.
Publicado: (2012)